Fengpeng Wu

466 total citations
24 papers, 294 citations indexed

About

Fengpeng Wu is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fengpeng Wu has authored 24 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fengpeng Wu's work include Colorectal Cancer Surgical Treatments (11 papers), Colorectal and Anal Carcinomas (9 papers) and Gastric Cancer Management and Outcomes (5 papers). Fengpeng Wu is often cited by papers focused on Colorectal Cancer Surgical Treatments (11 papers), Colorectal and Anal Carcinomas (9 papers) and Gastric Cancer Management and Outcomes (5 papers). Fengpeng Wu collaborates with scholars based in China, United States and Norway. Fengpeng Wu's co-authors include Yafan Yang, Shuguang Ren, Jianfeng Zhang, Feifei Wang, Xueying Qiao, Zhiming Dong, Joe Y. Chang, Li Cao, Xianli Meng and Xiaoling Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Fengpeng Wu

22 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fengpeng Wu China	8	147	143	136	46	34	24	294
Mara Gisabella Italy	7	199 1.4×	103 0.7×	182 1.3×	17 0.4×	41 1.2×	10	345
Lea Choung Wong Singapore	10	192 1.3×	182 1.3×	140 1.0×	22 0.5×	27 0.8×	15	422
Ofer Purim Israel	12	109 0.7×	152 1.1×	265 1.9×	104 2.3×	39 1.1×	45	403
Alexander V. Kirichenko United States	9	78 0.5×	145 1.0×	232 1.7×	67 1.5×	11 0.3×	28	288
Ki Young Yang South Korea	10	246 1.7×	222 1.6×	125 0.9×	13 0.3×	28 0.8×	15	393
Mirko Omejc Slovenia	10	80 0.5×	183 1.3×	174 1.3×	18 0.4×	35 1.0×	28	297
Brooke Vuong United States	11	166 1.1×	237 1.7×	365 2.7×	69 1.5×	52 1.5×	38	555
Duc Le Canada	10	97 0.7×	85 0.6×	153 1.1×	23 0.5×	67 2.0×	26	308
Kamal Haider Canada	11	133 0.9×	113 0.8×	345 2.5×	31 0.7×	45 1.3×	36	428
Franc Anderluh Slovenia	11	99 0.7×	251 1.8×	256 1.9×	13 0.3×	19 0.6×	31	369

Countries citing papers authored by Fengpeng Wu

Since Specialization

Citations

This map shows the geographic impact of Fengpeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengpeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengpeng Wu more than expected).

Fields of papers citing papers by Fengpeng Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengpeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengpeng Wu. The network helps show where Fengpeng Wu may publish in the future.

Co-authorship network of co-authors of Fengpeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengpeng Wu. A scholar is included among the top collaborators of Fengpeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengpeng Wu. Fengpeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Linlin, Jingyi Sun, Lu Wang, et al.. (2025). To Explore the Efficacy and Safety of Neoadjuvant Chemoradiation Therapy in Locally Advanced Colon Cancer: A Systematic Review and Meta-analysis. International Journal of Radiation Oncology*Biology*Physics. 123(3). 817–828. 1 indexed citations

Wu, Fengpeng, Linlin Xiao, Chaoxi Zhou, et al.. (2025). Short-course radiotherapy-based total neoadjuvant therapy combined with tislelizumab in the treatment of locally advanced rectal cancer (Neo-STAR): Early outcomes of a prospective, randomized phase II trial.. Journal of Clinical Oncology. 43(4_suppl). 150–150.

Xiao, Linlin, Shaoqiu Zhuo, Jingyi Sun, et al.. (2024). Could elective nodal irradiation for locally advanced rectal cancer be omitted in the context of total neoadjuvant therapy? An analysis of the recurrence sites of rectal cancer. Frontiers in Oncology. 14. 1459024–1459024.

Yang, Lei, Fengpeng Wu, Linlin Xiao, et al.. (2024). The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review. Frontiers in Immunology. 15. 1392499–1392499. 9 indexed citations

Zhou, Chaoxi, Xiaoxiao Zhang, Yuting Xiao, et al.. (2023). Assessing the predictive value of clinical factors to pathological complete response for locally advanced rectal cancer: An analysis of 124 patients. Frontiers in Oncology. 13. 1125470–1125470. 5 indexed citations

Xiao, Linlin, et al.. (2023). Case Report: Intervention of radiotherapy improves the prognosis of rectal squamous cell carcinoma with high PD-L1 expression and enable patients to obtain NED status. Frontiers in Immunology. 14. 1235697–1235697. 2 indexed citations

Xiao, Linlin, et al.. (2022). Could intracranial tumor volume predict prognosis of patients with brain metastases from esophageal carcinoma?. Thoracic Cancer. 13(8). 1193–1198. 2 indexed citations

Wu, Fengpeng, Xiaoxiao Zhang, Congrong Yang, et al.. (2022). The reduction of 18F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression. Frontiers in Oncology. 12. 1037783–1037783. 2 indexed citations

Wu, Fengpeng, et al.. (2021). Are People With Blood Group O More Susceptible to Nasopharyngeal Carcinoma and Have Worse Survival Rates? A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 698113–698113. 7 indexed citations

10.

Wu, Fengpeng, Xiaoxiao Zhang, Congrong Yang, et al.. (2021). Screening of MicroRNA Related to Irradiation Response and the Regulation Mechanism of miRNA-96-5p in Rectal Cancer Cells. Frontiers in Oncology. 11. 699475–699475. 5 indexed citations

11.

Lu, Shaoying, et al.. (2021). Use of MRI signal intensity ratio to differentiate between autoimmune pancreatitis and pancreatic ductal adenocarcinoma. Clinical Radiology. 77(1). e84–e91. 2 indexed citations

12.

Wu, Fengpeng, Chaoxi Zhou, Congrong Yang, et al.. (2020). Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer. PLoS ONE. 15(6). e0234310–e0234310. 1 indexed citations

13.

Wu, Fengpeng, et al.. (2020). Adding Adjuvants to Fluoropyrimidine-based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: An Option Worthy of Serious Consideration. Journal of Cancer. 12(2). 417–427. 2 indexed citations

14.

Wu, Fengpeng, Congrong Yang, Chaoxi Zhou, et al.. (2019). Volumetric imaging parameters are significant for predicting the pathological complete response of preoperative concurrent chemoradiotherapy in local advanced rectal cancer. Journal of Radiation Research. 60(5). 666–676. 4 indexed citations

15.

Yang, Yafan, et al.. (2017). Gender differences in colorectal cancer survival: A meta‐analysis. International Journal of Cancer. 141(10). 1942–1949. 118 indexed citations

16.

Yang, Yafan, et al.. (2017). Overall survival of patients with KRAS wild-type tumor treated with FOLFOX/FORFIRI±cetuximab as the first-line treatment for metastatic colorectal cancer. Medicine. 96(12). e6335–e6335. 7 indexed citations

17.

Yang, Yafan, et al.. (2016). Robotic gastrectomy versus open gastrectomy in the treatment of gastric cancer. Journal of Cancer Research and Clinical Oncology. 143(1). 105–114. 19 indexed citations

18.

Wu, Fengpeng, Jun Wang, Hui Wang, et al.. (2014). Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV neutropenia. Experimental and Therapeutic Medicine. 9(3). 761–765. 9 indexed citations

19.

Wu, Fengpeng, Hui Wang, Na Li, et al.. (2014). [Clinical observation of the salvage therapy using pegylated recombinant human granulocyte colony stimulating factor for grade IV neutropenia induced by concurrent chemoradiotherapy].. PubMed. 36(9). 708–12. 2 indexed citations

20.

Qiao, Xueying, Fengpeng Wu, Li Cao, et al.. (2007). Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. International Journal of Radiation Oncology*Biology*Physics. 67(2). 389–396. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact